Status:

COMPLETED

The Effect of Antiviral Therapy With Pegylated Interferon-alpha on Auditory Disability

Lead Sponsor:

Carmel Medical Center

Conditions:

Hearing Loss

Sudden Deafness

Eligibility:

All Genders

18-80 years

Brief Summary

The aim of the study is to assess the effect of antiviral therapy with pegylated interferon alpha for hepatitis C and B on auditory disability as there are reports in the English literature on auditor...

Detailed Description

The population to be studied: Patients with chronic hepatitis C or B treated by pegylated interferon- alpha. Trial Design Primary end-point: to assess the rate of auditory disability induced by pegyl...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Patients with chronic hepatitis C virus infection who will receive anti viral treatment consists of PEG-IFN-alpha-2a or 2b combined with ribavirin,
  • Patients with chronic hepatitis B who receive anti-viral treatment with PEG-IFN-alpha 2a (Pegasys)
  • Age 18-70 who are eligible for anti viral treatment.
  • Patients who attend and are treated in the Liver Unit of Haifa and Western
  • Galilee District of Clalit Health Services and Carmel Medical Center will be recruited.
  • Patients with all HCV genotypes will be included and will be treated by the standard-of-care therapy for hepatitis C: 48 weeks for genotypes 1 or 4.
  • Patients and 24 weeks for genotypes 2 or 3.
  • Virological response will be determined at week 12 of treatment. In non-responders therapy will be discontinued.
  • In those patients with genotype 1 and "'slow virological response", 72 weeks of therapy will be considered. Included will be also patients with chronic hepatitis B receiving PEG-IFN alpha 2a for up to 48 weeks.

Exclusion

    Key Trial Info

    Start Date :

    January 9 2011

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    March 26 2015

    Estimated Enrollment :

    100 Patients enrolled

    Trial Details

    Trial ID

    NCT01265693

    Start Date

    January 9 2011

    End Date

    March 26 2015

    Last Update

    July 24 2018

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    Carmel Medical Center

    Haifa, Israel, 34262

    2

    Carmel Medical Center

    Haifa, Israel, 34362